DNTH
Dianthus Therapeutics Inc.
90.70$
-2.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.10 | 0.03 | 0.05 | 0.06 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | |
| 0.02 | 0.10 | 0.03 | 0.05 | 0.06 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| 0.20 | 1.94 | 0.51 | 0.53 | 0.75 | 0.75 | 0.75 | 0.73 | 0.86 | 1.58 | 0.72 | 0.87 | 3.13 | |
| 0.22 | 1.02 | 0.22 | 0.18 | 0.19 | 0.19 | 0.20 | 0.25 | 0.22 | 0.26 | 0.26 | 0.24 | 0.79 | |
| 0.43 | 2.96 | 0.73 | 0.70 | 0.94 | 0.95 | 0.96 | 0.98 | 1.08 | 1.85 | 0.98 | 1.11 | 3.92 | |
| -0.40 | -2.86 | -0.70 | -0.65 | -0.87 | -0.91 | -0.93 | -0.98 | -1.07 | -1.84 | -0.97 | -1.10 | -3.89 | |
| -0.38 | -2.33 | -0.54 | -0.51 | -0.74 | -0.81 | -0.82 | -0.88 | -0.97 | 2.59 | -0.85 | -0.90 | -0.53 | |
| -0.03 | 0.19 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| -0.38 | -2.33 | -0.54 | -0.51 | -0.74 | -0.81 | -0.82 | -0.88 | -0.97 | 2.59 | -0.85 | -0.90 | -0.53 | |
| -0.38 | -2.31 | -0.53 | -0.51 | -0.73 | -0.81 | -0.82 | -0.88 | -0.97 | 2.60 | -0.85 | -0.90 | -0.53 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.